BTMD Stock Risk & Deep Value Analysis

Biote Corp

Healthcare • Medical Care Facilities

DVR Score

0.1

out of 10

Distressed

The Bottom Line on BTMD

We analyzed Biote Corp using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran BTMD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Mar 20, 2026•Run Fresh Analysis →

📈BTMD Performance Overview3yr weekly

📊

Unlock BTMD Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close · Quarterly revenue & EPS · DVR score history

BTMD Stock Risk Analysis

Overall Risk

N/A - Company is delisted and not publicly traded.

Financial Risk

N/A

Market Risk

N/A

About Biote Corp (BTMD)

Sector

Healthcare

Industry

Medical Care Facilities

Market Cap Category

small

Market Cap

$124.41M

BTMD Deep Value Analysis

As of today's date, 2026-03-20, Biote Corp. (BTMD) remains a delisted entity. The company was acquired by Tarsadia Investments for $10.50 per share in an all-cash transaction that closed on August 21, 2024. Following the acquisition, BTMD common stock ceased trading on the Nasdaq Global Market and was delisted. While a current price of $1.54 and market cap of $0.05B may appear in some data feeds, this does not represent an actively tradable public security with 10x growth potential on major exchanges. Therefore, fundamental analysis for public market investment is not applicable. This score reflects the non-investable status for public market investors, consistent with the previous analysis and without any material change since the last evaluation.

BTMD Red Flags & Warning Signs

Premium

⚠
N/A - Company is delisted and not publicly traded.

Unlock BTMD Red Flags & Risk Warnings

Premium members see every risk event we found.

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

🔥 New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

✓ Catalysts, bull case, moat & red flags
✓ Unlimited stock analyses + alerts
✓ Full database, search & portfolio (50 stocks)

Get Premium — $47/yr

7-day money back · Cancel anytime

BTMD Financial Health Metrics

Market Cap

$124.41M

P/E Ratio

3.29

BTMD Competitive Moat Analysis

Premium

Moat Rating

None

Moat Trend

N/A - Company is delisted and not publicly traded.

Moat Sources

1 Identified

N/A - Company is delisted and not publicly traded.

BTMD Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

BTMD Catalysts & Growth Drivers

Near-Term (0-6 months)

•N/A - Company is delisted and not publicly traded.

Medium-Term (6-18 months)

•N/A - Company is delisted and not publicly traded.

Long-Term (18+ months)

•N/A - Company is delisted and not publicly traded.

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

BTMD Bull Case: What Could Go Right

✓
N/A - Company is delisted and not publicly traded.

Bull Case Analysis

See what could go right with Premium

🔔

Never miss a move on BTMD

Create a free account to set price alerts and get notified on Telegram when BTMD hits your targets.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

FAQ

What is the DVR Score for Biote Corp (BTMD)?

As of March 20, 2026, Biote Corp has a DVR Score of 0.1 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Biote Corp?

Biote Corp's market capitalization is approximately $124.4M. The company operates in the Healthcare sector within the Medical Care Facilities industry.

What ticker symbol does Biote Corp use?

BTMD is the ticker symbol for Biote Corp. The company trades on the NGM.

What is the risk level for BTMD stock?

Our analysis rates Biote Corp's overall risk as N/A - Company is delisted and not publicly traded.. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of BTMD?

Biote Corp currently has a price-to-earnings (P/E) ratio of 3.3. This is below the market average, which could indicate the stock is undervalued or facing headwinds.

How often is the BTMD DVR analysis updated?

Our AI-powered analysis of Biote Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 20, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.